TOP HEADLINES

Featured Story

Report: Emergency flu vaccine manufacturing site will be online by 2017

One of three manufacturing sites commissioned by the Department of Health and Human Services to quickly develop and produce flu vaccines in the case of a pandemic is expected to be fully operational by 2017, officials say.

Colorado Senate hears vaccine bill testimony

Though the bill passed in the House after a bipartisan 42-19 vote, opponents have accused its sponsor of treating parents like "idiots" and "morons."

WHO offers road map for new vaccine introduction

To help countries achieve the maximum impact of new vaccines, the World Health Organization has released new guidance on how to introduce new vaccines in existing immunization programs.

Merck KGaA lung cancer vaccine gets a second shot with start of PhIII trial

Merck KGaA has breathed some life back into its lung cancer vaccine, which many wrote off after it tanked in a Phase III trial in late 2012. After vowing to make a renewed effort to find some value in the jab last September, this week the company announced the start of a new Phase III study.

Novartis' Bexsero wins FDA 'breakthrough' status

A couple of weeks ago, the FDA handed Pfizer's meningitis B candidate its breakthrough therapy designation, setting it up for a race to market with Novartis' Bexsero. Now, the Swiss company's jab has one to match, meaning it may not be long before it can start contributing some much-needed sales to Novartis' vaccines unit.

MORE NEWS

From Our Sister Sites

FiercePharma

After last week expressing her opinion that Massachusetts Governor Deval Patrick was "out of line" with his move to block controversial superstrength painkiller Zohydro, U.S. District Court Judge Rya Zobel granted maker Zogenix's request for an injunction temporarily halting the ban.

FierceMedicalDevices

Abbott Laboratories posted another quarterly decline in medical device revenue, but its fast-growing diagnostics business came through yet again.